The ELAINE trials and the future of personalized therapy for hormone-receptor positive metastatic breast cancer
-
Published:2023-12
Issue:12
Volume:34
Page:1071-1073
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Funder
Eli Lilly and Company
Genentech
Subject
Oncology,Hematology